Rutgers Cancer Institute of New Jersey, together with RWJBarnabas Health, has been redesignated by the National Cancer Institute (NCI) as a Comprehensive Cancer Center, placing it among the top centers in the country reviewed in 2023. The designation from the NCI, held by 56 such centers across the nation, is granted competitively to institutions characterized by the highest level of scientific excellence in cancer research and the ability to translate research discoveries into novel treatments. The institute at Rutgers scored in the “exceptional” range, according to the National Cancer Institute.
In its review of Rutgers Cancer Institute programs, the NCI recognized the institute’s innovative, paradigm-changing research, the impact on the relevant needs of the New Jersey population, notable community outreach, education and engagement efforts and strong integration with its research consortium partner Princeton University. To read the full story.